These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34207949)

  • 1. Structure of Nanobody Nb23.
    Percipalle M; Hunashal Y; Steyaert J; Fogolari F; Esposito G
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34207949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Easily Established and Multifunctional Synthetic Nanobody Libraries as Research Tools.
    Liu B; Yang D
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanobodies: natural single-domain antibodies.
    Muyldermans S
    Annu Rev Biochem; 2013; 82():775-97. PubMed ID: 23495938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of nanobodies in plant science and biotechnology.
    Wang W; Yuan J; Jiang C
    Plant Mol Biol; 2021 Jan; 105(1-2):43-53. PubMed ID: 33037986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction to heavy chain antibodies and derived Nanobodies.
    Vincke C; Muyldermans S
    Methods Mol Biol; 2012; 911():15-26. PubMed ID: 22886243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Basis of Epitope Recognition by Heavy-Chain Camelid Antibodies.
    Zavrtanik U; Lukan J; Loris R; Lah J; Hadži S
    J Mol Biol; 2018 Oct; 430(21):4369-4386. PubMed ID: 30205092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A specific nanobody prevents amyloidogenesis of D76N β
    Raimondi S; Porcari R; Mangione PP; Verona G; Marcoux J; Giorgetti S; Taylor GW; Ellmerich S; Ballico M; Zanini S; Pardon E; Al-Shawi R; Simons JP; Corazza A; Fogolari F; Leri M; Stefani M; Bucciantini M; Gillmore JD; Hawkins PN; Valli M; Stoppini M; Robinson CV; Steyaert J; Esposito G; Bellotti V
    Sci Rep; 2017 Apr; 7():46711. PubMed ID: 28429761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical shift assignments of a camelid nanobody against aflatoxin B
    Nie Y; Li S; Zhu J; Hu R; Liu M; He T; Yang Y
    Biomol NMR Assign; 2019 Apr; 13(1):75-78. PubMed ID: 30328057
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Sounier R; Yang Y; Hagelberger J; Granier S; Déméné H
    Biomol NMR Assign; 2017 Apr; 11(1):117-121. PubMed ID: 28239762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic analysis of allosteric and non-allosteric effects arising from nanobody binding to two epitopes of the dihydrofolate reductase of Escherichia coli.
    Oyen D; Wechselberger R; Srinivasan V; Steyaert J; Barlow JN
    Biochim Biophys Acta; 2013 Oct; 1834(10):2147-57. PubMed ID: 23911607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ¹⁵N, ¹³C and ¹H resonance assignments and secondary structure determination of a variable heavy domain of a heavy chain antibody.
    Prosser CE; Waters LC; Muskett FW; Veverka V; Addis PW; Griffin LM; Baker TS; Lawson AD; Wernery U; Kinne J; Henry AJ; Taylor RJ; Carr MD
    Biomol NMR Assign; 2014 Apr; 8(1):113-6. PubMed ID: 23359223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in nanobody and its application in diagnosis].
    Kong Q; Yao Y; Chen R; Lu S
    Sheng Wu Gong Cheng Xue Bao; 2014 Sep; 30(9):1351-61. PubMed ID: 25720150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Camelid single-domain antibody fragments: Uses and prospects to investigate protein misfolding and aggregation, and to treat diseases associated with these phenomena.
    Pain C; Dumont J; Dumoulin M
    Biochimie; 2015 Apr; 111():82-106. PubMed ID: 25656912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanobodies as probes to investigate purinergic signaling.
    Eggers M; Rühl F; Haag F; Koch-Nolte F
    Biochem Pharmacol; 2021 May; 187():114394. PubMed ID: 33388283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanobodies: From Serendipitous Discovery of Heavy Chain-Only Antibodies in Camelids to a Wide Range of Useful Applications.
    Ji F; Ren J; Vincke C; Jia L; Muyldermans S
    Methods Mol Biol; 2022; 2446():3-17. PubMed ID: 35157266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanobodies as Probes for Protein Dynamics in Vitro and in Cells.
    Dmitriev OY; Lutsenko S; Muyldermans S
    J Biol Chem; 2016 Feb; 291(8):3767-75. PubMed ID: 26677230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Production and Characterization of VHHs/Nanobodies Targeting Tau to Block Fibrillar Assembly.
    Mortelecque J; Danis C; Landrieu I; Dupré E
    Methods Mol Biol; 2024; 2754():131-146. PubMed ID: 38512665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solution structure and backbone dynamics of an antigen-free heavy chain variable domain (VHH) from Llama.
    Renisio JG; Pérez J; Czisch M; Guenneugues M; Bornet O; Frenken L; Cambillau C; Darbon H
    Proteins; 2002 Jun; 47(4):546-55. PubMed ID: 12001233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanobody Paratope Ensembles in Solution Characterized by MD Simulations and NMR.
    Fernández-Quintero ML; DeRose EF; Gabel SA; Mueller GA; Liedl KR
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of nanobodies against epithelial cell adhesion molecule as novel theranostic agents for cancer therapy.
    Roshan R; Naderi S; Behdani M; Cohan RA; Ghaderi H; Shokrgozar MA; Golkar M; Kazemi-Lomedasht F
    Mol Immunol; 2021 Jan; 129():70-77. PubMed ID: 33183767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.